Acarbose and Ramipril: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 10, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Ramipril
Acarbose
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You've been prescribed ramipril (a blood pressure medicine) and acarbose (a diabetes medicine that slows how you absorb sugar from food). When these are taken together, there's a small chance your blood sugar could drop lower than usual, which we call hypoglycemia. That might feel like shakiness, sweating, dizziness, or feeling suddenly hungry.
The good news is this concern is mostly theoretical, meaning it's based on how the drugs might interact rather than strong real-world proof. Your care team can manage it easily by checking your blood sugar a bit more often, especially when either medicine is started or stopped. Keep taking both as prescribed and let your pharmacist or doctor know if you notice low-sugar symptoms.
Effect: Theoretical increased risk of hypoglycemia with ACE inhibitor (ramipril) plus antidiabetic agent (acarbose).
- Direction: Potentiation of glucose-lowering effect. Neither agent is a prodrug relevant here; mechanism is unknown/pharmacodynamic (ACE inhibitors may enhance insulin sensitivity).
- Evidence: Theoretical, low substantiation. A self-controlled case series found no increased serious hypoglycemia with ACE inhibitors plus insulin secretagogues, possibly excepting glimepiride. Acarbose itself rarely causes hypoglycemia as monotherapy.
- Onset: Unspecified.
- Management: Increase glucose monitoring during concomitant use and after ACE inhibitor withdrawal. Individualize antidiabetic dosing as needed.
What happens
An increased risk of hypoglycemia
Interaction Deep Dive
Taking ACE inhibitors together with antidiabetic medications can heighten the likelihood of hypoglycemia134. When their combined use cannot be avoided, glucose should be checked more often, not only throughout therapy but also once an ACE inhibitor is discontinued 2. It may additionally be necessary to modify insulin dosing 13. Evidence from a self-controlled case series indicates that pairing ACE inhibitors with insulin secretagogues does not correlate with higher rates of serious hypoglycemia, though glimepiride may represent an exception 5.
Why it happens (mechanism)
Unknown
How to manage this interaction
This interaction is usually straightforward to manage, and you should keep taking both medicines as prescribed unless your prescriber tells you otherwise.
- Your care team may check your blood sugar more often, particularly when ramipril is started, changed, or stopped.
- Your diabetes medication dose may need to be adjusted and individualized by your team based on your readings.
- Learn the signs of low blood sugar (shakiness, sweating, confusion, hunger) and treat them promptly.
Bring your glucose logs to appointments and ask your pharmacist or doctor any questions about timing or symptoms.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) A self-controlled case series examined Medicare claims data drawn from 5 states between 1999 and 2011 to assess simultaneous use of ACE inhibitors together with insulin secretagogues (glimepiride, glipizide, glyburide, nateglinide, and repaglinide) or metformin (serving as a negative control). The measured outcome was hospital presentation for serious hypoglycemia. During the observation period, the counts of serious hypoglycemic events were 8159, 14,353, 11,129, 1595, 2901, and 32,639 for glimepiride, glipizide, glyburide, nateglinide, repaglinide, and metformin, respectively. The confounder-adjusted rate ratio (RR) showed no significant elevation with glipizide, glyburide, repaglinide, or metformin, but was slightly increased with glimepiride (RR, 1.23; 95% CI, 1.11 to 1.37) and slightly decreased with nateglinide (RR, 0.73; 95% CI, 0.56 to 0.96). Apart from glimepiride, these findings indicate that concurrent use of an ACE inhibitor and insulin secretagogues was not linked to a heightened risk of serious hypoglycemia 5.
Common questions
Can I take Acarbose and Ramipril together?
Taking ramipril with acarbose may slightly raise the chance of low blood sugar, so keep both as prescribed and check your glucose more often, especially when either drug is started or stopped. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Acarbose and Ramipril interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Acarbose and Ramipril interaction managed?
This interaction is usually straightforward to manage, and you should keep taking both medicines as prescribed unless your prescriber tells you otherwise. Your care team may check your blood sugar more often, particularly when ramipril is started, changed, or stopped. Your diabetes medication dose may need to be adjusted and individualized by your team based on your readings. Learn the signs of lo… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Acarbose or Ramipril need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
References (5)
- Product Information: TOUJEO(R) subcutaneous injection, insulin glargine subcutaneous injection. sanofi-aventis (per manufacturer), Bridgewater, NJ, 2015. DailyMed
- Product Information: AMARYL(R) oral tablets, glimepiride oral tablets. Sanofi-Aventis U.S. LLC (per FDA), Bridgewater, NJ, 2013. DailyMed
- Product Information: AFREZZA(R) oral inhalation powder, insulin human oral inhalation powder. MannKind Corporation(TM) (per manufacturer), Danbury, CT, 2014. DailyMed
- Product Information: Zestril(R) oral tablets, lisinopril oral tablets. AstraZeneca Pharmaceuticals LP (per FDA), Wilmington, DE, 2014. DailyMed
- Hee Nam Y, Brensinger CM, Bilker WB, et al: Angiotensin-converting enzyme inhibitors used concomitantly with insulin secretagogues and the risk of serious hypoglycemia. Clin Pharmacol Ther 2022; 111(1):218-226. PubMed
Keep reading about Ramipril
Keep reading about Acarbose
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist